Skip to content
Search

Latest Stories

Systematic investment plans gain momentum in India

Systematic investment plans gain momentum in India

INFLOWS into the mutual fund industry through systematic investment plans (SIPs) reached close to Rs 670 billion (£6.7 bn) in the first seven months of the ongoing fiscal, suggesting the growing popularity of staggered investments.

This comes following an inflow of Rs 960.80 bn (£9.6 bn) through the route in 2020-21, data with the Association of Mutual Funds in India (Amfi) showed.


Moreover, mutual fund SIP contribution has seen a more than two-fold rise during the last five years. It was at Rs 439.21 bn (£4.39 bn) during 2016-17.

Also, the monthly collection through SIP surged to an all-time high of Rs 105 bn (£1.05 bn) in October, higher than Rs 103.5 (£1.03 bn) in September.

SIPs' assets under management (AUM) climbed to Rs 5.53 trillion (£55 bn) at the end of October from Rs 4.28 tn (£43 tn) in March-end.

Over the past five years, SIP AUM has grown 30 per cent annually, twice as fast as the growth in the overall mutual fund industry's assets base.

Some 2.38 million new SIPs were registered in October. The total registrations reached to 15m in the first seven months (April-October) of the current fiscal. This was way higher than the 14.1m new SIP registrations in the entire preceding financial year.

Currently, mutual funds have about 46.4m SIP accounts through which investors regularly invest in mutual fund schemes

"Staggered investment approach (via SIP or STP) in equity markets seems the ultimate solution to ride the wave of uncertainty as corrections would bring down the average cost of your total investments or in case the bull run continues, investors would not lose out on opportunity cost," said Akshat Garg, manager, research at Investica, a platform for investing in mutual funds.

SIP is an investment methodology offered by mutual funds wherein an individual saver can invest a fixed amount in a chosen scheme periodically at fixed intervals, instead of making a lump-sum investment.

The SIP instalment amount can be as small as Rs 500 (£5) per month.

According to Amfi, SIPs have been gaining popularity among Indian savers, as it helps in investing in a disciplined manner without worrying about market volatility or timing the market.

The 45-player mutual fund industry mainly depends on SIPs for inflows, with equity mutual funds attracting Rs 52 bn (£520m) in October, making it the eighth consecutive monthly infusion.

However, the quantum of net inflows dropped from Rs 86.77 bn (£867m) logged in September.

Harshad Chetanwala, a co-founder, MyWealthGrowth.com, said subscriptions in equity funds were lower compared to September as markets were a bit volatile in October and investors may have followed a wait and watch or staggered investing approach which is better in current market conditions.

"At the same time, there is a possibility that some of the outflows from these funds would have gone back to international funds and balanced funds launched during recent times," he added.

The debt segment saw net inflows to the tune of Rs 129.84 bn (£1.3 bn) last month, after seeing a net withdrawal of Rs 639.1 bn (£6.4 bn) in September.

(PTI)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less